Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Ensysce Biosciences, Inc. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -207.71% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -8.23
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -84.67%, its profits have fallen by -38.1%
3
Below par performance in long term as well as near term
- Along with generating -84.67% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Ensysce Biosciences, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Ensysce Biosciences, Inc.
-84.51%
-0.62
152.07%
S&P 500
13.68%
0.71
19.28%
Quality key factors
Factor
Value
Sales Growth (5y)
40.58%
EBIT Growth (5y)
-207.71%
EBIT to Interest (avg)
-8.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.92
Sales to Capital Employed (avg)
1.43
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
20.47%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.30
EV to EBIT
-0.02
EV to EBITDA
-0.02
EV to Capital Employed
-0.25
EV to Sales
0.06
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-912.10%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
Bullish
Bullish
Technical Movement
8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -7.05 MM
NET PROFIT(HY)
Higher at USD -5.46 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at -108.79 %
-23What is not working for the Company
NET SALES(HY)
At USD 1.86 MM has Grown at -48.22%
OPERATING PROFIT(Q)
Lowest at USD -3.74 MM
PRE-TAX PROFIT(Q)
Lowest at USD -3.73 MM
NET PROFIT(Q)
Lowest at USD -3.73 MM
Here's what is working for Ensysce Biosciences, Inc.
Operating Cash Flow
Highest at USD -7.05 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Debt-Equity Ratio
Lowest at -108.79 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Ensysce Biosciences, Inc.
Net Sales
At USD 1.86 MM has Grown at -48.22%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -3.73 MM has Fallen at -669.17%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -3.73 MM has Fallen at -669.17%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Profit
Lowest at USD -3.74 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -3.73 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -3.73 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)






